Daniel Faga - 07 Jan 2026 Form 4 Insider Report for ANAPTYSBIO, INC (ANAB)

Reporting relationship: President, CEO, Director
Issuer ticker: ANAB
Reported as of: 07 Jan 2026
Net transaction value: -$638,504
SEC form: 4
Accepted by SEC: 09 Jan 2026, 19:12:18 UTC
Prior SEC filing: 08 Jan 2026
Next SEC filing: 27 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Eric Loumeau, Attorney-in-Fact

Key filing fact

Daniel Faga filed Form 4 for ANAPTYSBIO, INC (ANAB) on 09 Jan 2026.

Key facts

This page summarizes Daniel Faga's Form 4 filing for ANAPTYSBIO, INC (ANAB).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 09 Jan 2026, 19:12.

Change

Previous filing in this sequence was filed on 08 Jan 2026.
Current net transaction value: -$638,504.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001673528 Primary reporting owner

Faga Daniel

Relationship: President, CEO, Director
Address: C/O ANAPTYSBIO, INC., 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO
Signature: /s/ Eric Loumeau, Attorney-in-Fact
Signature date: 09 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ANAB transaction

Common Stock

Options Exercise

Transaction value
Shares: +26,838
Change %: +5.7%
Price
Shares after: 493,625
Date: 07 Jan 2026
Ownership: Direct
Footnotes: F1

ANAB transaction

Common Stock

Sale

Transaction value: $638,504
Shares: -14,281
Change %: -2.9%
Price: $44.71
Shares after: 479,344
Date: 08 Jan 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ANAB transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value: $0
Shares: -26,838
Change %: -25%
Price: $0.000000
Shares after: 80,512
Date: 07 Jan 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 26,838
Exercise price
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Footnote F2

The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Footnote F3

The RSUs vests as to 25% of the total RSUs annually commencing on January 7, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.